Zurn Elkay director gets 503 share fee grant
Zurn Elkay Water Solutions director Rosemary Schooler reported receiving 503 shares of common stock on January 15, 2026.
Rhea-AI Filing Summary
Zurn Elkay Water Solutions director Rosemary Schooler reported receiving 503 shares of common stock on January 15, 2026. The shares were acquired at a reference price of $47.27 per share as payment of director fees in the form of restricted stock units. According to the filing, these units vested immediately but will not be paid out until six months after she ceases serving as a director.
After this grant, Schooler beneficially owns 58,344 shares of Zurn Elkay common stock, held directly. The transaction is coded as an acquisition and reflects equity-based compensation rather than an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 503 | $47.27 | $24K |
Footnotes (1)
- F1. Payment of director fees in restricted stock units, which vested immediately, but is not paid out until six months after the Reporting Person's cessation of service as a director.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Zurn Elkay (ZWS) report for Rosemary Schooler?
Rosemary Schooler, a director of Zurn Elkay Water Solutions, reported an acquisition of 503 shares of common stock on January 15, 2026, shown as equity compensation.
When do Rosemary Schooler’s restricted stock units in Zurn Elkay get paid out?
The restricted stock units vested immediately but are not paid out until six months after Rosemary Schooler’s cessation of service as a director.
Was the Zurn Elkay (ZWS) Form 4 transaction an acquisition or a sale?
The Form 4 lists the transaction code as "A" for acquisition, indicating that shares were acquired as compensation rather than sold.
AI-generated analysis. How Rhea-AI works. Not financial advice.